Risk factor-based cancer auxiliary discrimination method, equipment and program product
Through the cancer-assisted discrimination method based on risk factors, using risk discrimination models and feature importance scoring, the problem of lack of scientific risk assessment in renal cancer treatment decisions was solved, and more accurate renal cancer risk assessment and personalized treatment plan recommendations were achieved.
Patent Information
- Application Number
- CN202510351609.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-03-24
- Publication Date
- 2025-06-27
AI Technical Summary
The lack of scientific and systematic risk assessment tools in the treatment decisions of renal cancer in the existing technology, which makes it difficult to dynamically adjust the treatment strategies, balance the efficacy and toxicity, integrate multidisciplinary opinions, and deal with tumor heterogeneity.
Provide a cancer-assisted discrimination method based on risk factors. By acquiring clinical data, extracting risk factor characteristics, using a risk discrimination model (through information gain and/or Gini index gain training), and scoring in combination with feature importance, it recommends treatment options.
This method can help doctors diagnose renal cancer risk results more objectively and comprehensively, optimize treatment plans, and improve the feasibility and reliability of medical decisions.